Gemcitabine-associated diffuse alveolar hemorrhage.
Carron
P L
PL
Cousin
L
L
Caps
T
T
Belle
E
E
Pernet
D
D
Neidhardt
A
A
Capellier
G
G
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D018287:Carcinoma, Large Cell / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D017809:Fatal Outcome; D006470:Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D011650:Pulmonary Alveoli / Q000187:drug effects*; D013256:Steroids; D000093542:Gemcitabine
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000964:Antimetabolites, Antineoplastic; D013256:Steroids; D003841:Deoxycytidine; D000093542:Gemcitabine